Wellness
UCL spin-out raises £2.5m to improve infant health with breast milk microbiome

London-based biotechnology company BoobyBiome has raised £2.5m in seed funding for its infant feeding solutions.
The funding round was led by specialist deep tech investor Empirical Ventures, alongside The Helm, XFactor Ventures, Lavender Ventures, Kayan Ventures, and Evenlode Investment, with influential angels including Dominic Hollamby, Lord Ara Darzi, Yael Cohen, Vanessa Colomar, and others.
Founded in 2019 by a team of female scientists-turned-entrepreneurs, the company plans to tackle the rising rates of infant health issues by harnessing the breast milk microbiome.
Dr Lydia Mapstone, Chief Executive Officer, BoobyBiome, said: “This funding marks a major milestone in our mission to revolutionise infant feeding and ensure every baby has equal access to a healthy future.
“It represents five years of dedication to understanding breast milk and harnessing its power for infant health.”
The prevalence of infant health issues linked to inadequate microbiome development, such as food allergies, asthma, type 1 diabetes, and obesity, is continuing to rise.
The breast milk microbiome – a diverse blend of beneficial bacteria found in human milk – plays a crucial role in strengthening infant immune defences against these diseases.
While breastfeeding offers well-established health benefits, it can sometimes be challenging due to a range of medical, physical, or personal factors, meaning not all families are able to exclusively breastfeed.
BoobyBiome has set out to redress this disparity in infant feeding.
Based on over five years of research at the UCL Great Ormond Street Institute of Child Health, it has created the world’s largest high-resolution breast milk microbiome database.
BoobyBiome has also produced a biobank of proprietary strains, capturing the diversity of beneficial bacteria found in human milk samples.
This has enabled the identification, characterisation, and preservation of strains critical for infant gut and immune development.
This latest funding will advance the commercial launch of BoobyBiome’s proprietary storage device, including partnerships with global infant bottle companies.
It will also enable the ongoing research and development of its live microbiome drop and the expansion of BoobyBiome’s commercial team as it scales internationally.
Dr Sioned Jones, Chief Operating Officer, BoobyBiome, said: “In closing this gap, we also aim to reduce the stigma often faced by parents who, for many reasons, cannot breastfeed.
“This support will allow us to advance our research, bring our live microbiome drops closer to market, and deliver meaningful improvements to infant health worldwide.”
Dr Tara O’Driscoll, Chief Technology Officer, BoobyBiome, said: “We founded BoobyBiome in response to rising infant diseases linked to low breastfeeding rates and underdeveloped microbiomes.
“Like many issues in infant health, it remains under-researched and under-funded, and we hope our work helps drive greater investment into this vital field.”
Dr Ben Miles, Co-Founder and General Partner, Empirical Ventures, said: “We’re proud to support the brilliant team at BoobyBiome as they advance their research and bring their groundbreaking technology to market.
“Lydia, Sioned, and Tara’s combined expertise makes them exceptionally well placed to transform infant health, and their work addresses a critical gap that has been overlooked for too long.
“At Empirical Ventures, we believe entrepreneurial scientists like the BoobyBiome team are uniquely capable of driving real, positive change in the world.
“We’re excited to back their journey and to see the impact this innovation will have on families everywhere.”
Mental health
Women over 40 seeking raves for mental health benefits
Wellness
WUKA brings Period-Positive Pool Party to London Aquatics Centre to keep girls swimming through puberty

This summer, WUKA and triple Olympian Hannah Miley MBE are bringing their Period-Positive Pool Party to London Aquatics Centre with one clear mission: to prove that periods should never keep anyone out of the water
At a time when 84 per cent of teenage girls in the UK say their interest in sport declines after starting their period – and nearly 70 per cent report skipping sports or swimming due to menstruation – WUKA’s immersive community event is tackling one of the most overlooked barriers to girls’ participation head-on.
WUKA’s Period-Positive Pool Party was created as a safe, inclusive space for teens to swim on their periods with confidence.
Following a series of sold-out events across the UK, including Eastleigh and Stonehaven in Hannah Miley’s hometown of Aberdeen, the London-based Olympic venue is a result of growing demand from teens and parents seeking supportive, stigma-free spaces to stay active during menstruation.
Why This Matters?
For many young people – particularly those who are not ready to use tampons due to age, comfort, cultural reasons, or parental guidance – swimming during their period can feel inaccessible.
WUKA’s period swimwear offers an alternative designed to provide comfort, coverage, and confidence, helping ensure that periods don’t mean sitting on the sidelines.
The new one-hour London takeover combines swimming, education, and empowerment in one of the UK’s most iconic sporting venues.
Breaking The Stigma While Making A Splash
So much more than a product event, WUKA’s Period-Positive Pool Party is a fully immersive experience featuring a DJ-approved summer playlist, inflatable pool installations, and professional underwater photography capturing barrier-free swimming moments. Every teen will also receive a curated £80 wellness goodie bag, including free WUKA swimwear.
But more than anything, they’re about freedom, confidence, and belonging, ensuring the confidence to swim, period, or not, continues long after they leave the water.
Hannah Miley MBE says: “Being an athlete taught me that your cycle isn’t a weakness, it’s just something to manage.
“Partnering with WUKA for this Pool Party is about showing young swimmers that with the right support and the right kit, they don’t have to press pause on their lives or their sport because of their period.”
WUKA Founder Ruby Raut says: “This is about more than a pool party – it’s about changing what inclusion in sport actually looks like.
“Too many girls step back from swimming and physical activity because of period stigma or lack of options.
“Through community-led events like this, we’re breaking barriers, building confidence, and making sure no one feels excluded from sport because of their cycle.”
Saturday 30th May 2026 | 5–6pm | London Aquatics Centre
Want to join the pool party? Follow this link to buy your tickets
Pregnancy
App tracks heart risk after high-risk pregnancies

A recent study developed a new “digital companion” to support the prevention and follow-up of maternal cardiovascular risk in women with pregnancy complications.
Cardiovascular disease, or CVD, is the leading cause of premature death and illness in women, yet sex-specific causes remain understudied and women are underrepresented in research.
Pregnancy complications, including hypertensive disorders of pregnancy, or HDP, and gestational diabetes mellitus, or GDM, are strong predictors of future CVD, with pregnancy itself acting as a natural stress test.
Despite CVD accounting for 35 per cent of female deaths worldwide in 2019, systematic postpartum prevention remains limited in practice and incidence continues to rise.
Myocardial infarction, commonly known as heart attack, and stroke are the main fatal CVD events in women. Up to one-third of women develop hypertension within a decade after HDP, especially as maternal age rises.
Obstetric guidelines have historically lacked clarity on early CVD prevention after HDP and GDM, often relying on expert consensus rather than evidence.
Some cardiology guidelines now recommend personalised approaches, such as periodic hypertension and diabetes screening. Norwegian guidelines recommend cardiovascular risk evaluation at three months and one year postpartum, but adherence in practice is uncertain.
Effective risk reduction requires intervention before middle age. The immediate postpartum period following HDP or GDM is a critical window for early detection and intervention, offering an opportunity to engage women in cardiovascular health management, particularly as pregnancy can encourage long-term lifestyle awareness.
Electronic health, or eHealth, refers to the use of digital technologies and electronic communication tools to support healthcare services, medical information management and related health activities.
Systematic, eHealth-supported postpartum prevention can improve maternal health literacy and long-term cardiovascular outcomes.
However, there is a significant gap in targeted, eHealth-based postpartum interventions for cardiovascular risk management after HDP and GDM, despite strong patient demand and international calls for coordinated digital health strategies.
Home blood pressure monitoring shows promise, but broader digital support remains limited.
A cardiovascular postpartum follow-up programme was created as a mobile app based on Norwegian and international guidelines.
The MumCare app was developed through co-creation involving users, stakeholders and clinical experts. Five qualitative interviews and 10 user testing sessions informed improvements.
This study primarily analysed the iterative co-creation process used to develop the app, rather than evaluating clinical outcomes.
The MumCare project team in Oslo included an IT expert, obstetricians, a midwife, a GP, two sociologists and two cardiologists, all with relevant experience in eHealth and women’s health. A medical student with technological and medical expertise also helped turn ideas into app features for young women.
User representatives from two national patient associations contributed to information, recruitment, design and testing of the MumCare app.
Both associations provided user perspectives and took part in interviews and app testing. Additional users with HDP or GDM at Oslo University Hospital were also involved throughout the co-creation process.
The app’s digital infrastructure prioritises security and privacy, using encryption, de-identification and two-factor authentication.
User data is stored securely on the app and, for research purposes and with consent, on a dedicated University of Oslo server in line with GDPR and Norwegian regulations.
A linear Stage-Gate model structured the co-creation process, dividing it into phases with quality checkpoints reviewed in project meetings.
This approach balanced internal development with external user feedback, helping ensure the app is evidence-based, technically robust and user-centred.
The MumCare app guides postpartum women through tracking blood pressure, weight, physical activity and lab results, and provides personalised feedback to support self-management, mainly during the first postpartum year.
It also includes educational resources such as videos and guideline-based information to support understanding and engagement.
The app is also designed to support the transition from specialist pregnancy care to long-term follow-up with general practitioners.
It is described as a “digital companion” or health coach and does not replace clinical diagnosis or function as a medical device.
The co-creation process followed four phases focused on technical and procedural development.
In phase 1, input from expert organisations and user representatives established the app’s technical foundation.
It also reminds users of the one-year postpartum follow-up with their GP, a key time to assess risk factors and future care needs.
User organisation representatives gave feedback in phase 1, directly guiding content and feature development.
Phase 2 interviews confirmed that users want to monitor cardiovascular risk factors after HDP and GDM.
The analysis highlighted three themes: self-care strategies and uncertainties about hypertension, the need for accessible health information, and a more personalised approach to blood pressure monitoring in the app.
Concerns were also raised that frequent monitoring or app use could increase stress or create a sense of burden.
In phase 3, the app’s design and features were revised in response to feedback to improve usability and make sure they met users’ needs.
These changes led to a more intuitive and supportive interface for women during and after pregnancy.
Phase 4 involved building a prototype based on the updated designs, followed by further refinements after testing by the project team and users. Initial pilot testing with a small number of users suggested the app met its objectives and functioned as intended.
The MumCare app was co-created with input from experts, user organisations and patients over four phases.
Early expert and organisational contributions helped define the app’s goals, while ongoing feedback from patients helped ensure the design and content reflected users’ real needs.
This collaborative approach resulted in an app tailored to support women with pregnancy complications.
The MumCare app is currently being evaluated in a randomised controlled clinical trial that began in June 2024, with results needed to determine whether it improves long-term cardiovascular outcomes.
Entrepreneur4 weeks agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
News3 weeks agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Diagnosis4 weeks agoNew meta-analysis further supports low re-excisions and high placement accuracy with the Magseed marker
Pregnancy4 weeks agoNIPT or NT scan? Why the 2026 evidence supports doing Both
News4 weeks agoResistance training has preventative effects in menopause, study finds
Mental health4 weeks agoLifting weights shows mental health and cognitive benefits in older women, study finds
Insight3 weeks agoWhy the UK’s fertility rate keeps falling – and what it means if you’re trying now
Wellness3 weeks agoWomen’s HealthX unveils Northwell Health, Corewell Health, Biogen & more to headline Chronic Disease stage















